RnRMarketResearch.com adds “OpportunityAnalyzer: Allergic Rhinitis: Allergen-Specific Immunotherapy – Opportunity Analysis and Forecast to 2018” to its store.
The US market value for allergic rhinitis treatment will rise rapidly from $172.5 million in 2013 to $688.25 million by 2018, at an impressive Compound Annual Growth Rate...
More...
